Exit of the Year – IPO

Exit of the Year – IPO

Innovent Biologics (6 Dimensions Capital/Ally Bridge Group/Capital Group Private Markets/Cormorant Asset Management/Cowin Capital/Eight Roads Ventures/F-Prime Capital/Hillhouse Capital/Legend Capital/Lilly Asia Ventures/Rock Springs Capital/Temasek Holdings)

share